Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|---|---|---|---|
|
Å×¶ó·ÐÁ¤ - »õâ
|
¿µÀÏÁ¦¾à |
A16604201 | Terazosin HCl | Àü¹®ÀǾàǰ | »èÁ¦ |
|
Çѿÿ°»êÅ×¶óÁ¶½ÅÁ¤ - »õâ
|
ÇÑ¿ÃÁ¦¾à |
A03505201 | Terazosin HCl | Àü¹®ÀǾàǰ | »èÁ¦ |
|
¶óÁ¶³ªÁ¤1mg - »õâ
|
³Ø½ºÆÊÄÚ¸®¾Æ |
A66300461 | Terazosin HCl | Àü¹®ÀǾàǰ | »èÁ¦ |
|
ÄɶóÁ¶½ÅÁ¤1mg - »õâ
|
ÄÉÀÌ¿¥¿¡½ºÁ¦¾à |
A32202591 | Terazosin HCl | Àü¹®ÀǾàǰ | »èÁ¦ |
|
À¯´ÏÆ®¸°Á¤1mg - »õâ
|
Çѱ¹À¯´Ï¿ÂÁ¦¾à |
A12202431 | Terazosin HCl | Àü¹®ÀǾàǰ | ±Þ¿© |
|
¹Ù¼ÒÁ¶½ÅÁ¤2mg - »õâ
|
ÀÏÈ |
A06502211 | Terazosin HCl | Àü¹®ÀǾàǰ | ±Þ¿© |
|
Å×·¹½ÅÁ¤2mg - »õâ
|
ÀÌÅØ½ºÁ¦¾à |
A18701891 | Terazosin HCl | Àü¹®ÀǾàǰ | ±Þ¿© |
|
Å×¶óƾÁ¤ - »õâ
|
ÇѸ²Á¦¾à |
A37803621 | Terazosin HCl | Àü¹®ÀǾàǰ | »èÁ¦ |
|
Å×¶óÁøÁ¤ - »õâ
|
À§´õ½º¸ÞµðÆÊ |
A23003981 | Terazosin HCl | Àü¹®ÀǾàǰ | ±Þ¿© |
|
Å×·¹Á¸Á¤ - »õâ
|
¿¡½º¾ØÇÇÁ¦¾à |
A81300021 | Terazosin HCl | Àü¹®ÀǾàǰ | »èÁ¦ |
| teratogen |
Any substance capable of producing structural abnormalities of prenatal origin, present at birth or manifested shortly thereafter.
Ãâó: www.uoguelph.ca/GTI/urbanpst/glossn_z.htm
|
|---|---|
| teratogenic |
The ability to produce birth defects. A teratogenic agent has the ability to induce or increase the incidence of congenital malformations, ie, permanent structural or functional deviations arising during embryogenesis.
Ãâó: www.uoguelph.ca/GTI/urbanpst/glossn_z.htm
|
| teratogen |
This is the descriptor applied to any substance that can cause non-heritable birth defects.
Ãâó: www.bio.hw.ac.uk/edintox/glossall.htm
|
| teratogenesis |
Teratogenesis is the production of non-heritable birth defects.
Ãâó: www.bio.hw.ac.uk/edintox/glossall.htm
|
| teratogenicity |
The property or capability of producing fetal malformation.
Ãâó: www.nbc-med.org/SiteContent/MedRef/OnlineRef/Field...
|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|